RxDoctor Payments Data

Megan Klaus, APRN

Family · Riverview, FLNPI 1497163281

Payments from drug & device makers

$5,094in general payments, 2019–2025

Across 280 payments — averaging $18.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$565
  • Lucid Diagnostics Inc.$538
  • AstraZeneca$423
  • Lilly USA, LLC$395
  • Pfizer$336
  • Novo Nordisk$287
  • plus $3K from 33 others

What the payments were for

  • Food & beverage$5,03099%
  • Education$651%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,094 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$16,470
Medicare patients
71
Services billed
248

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide36$50,828
JardianceEmpagliflozin22$37,358
EliquisApixaban27$30,771
MounjaroTirzepatide25$27,825
FarxigaDapagliflozin Propanediol23$26,660
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$11,022
Bevespi AerosphereGlycopyrrolate/Formoterol Fum18$8,215
SynthroidLevothyroxine Sodium16$1,612
Rosuvastatin Calcium141$952
Nifedipine ErNifedipine33$948
Estradiol14$787
Atorvastatin Calcium132$772
Telmisartan22$657
Albuterol Sulfate HfaAlbuterol Sulfate20$636
Valsartan40$627

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$287$50,82836 claims
Boehringer IngelheimJardiance$116$37,35822 claims
AstraZenecaFarxiga, Bevespi Aerosphere$423$34,87641 claims
PfizerEliquis$336$30,77127 claims
Lilly USA, LLCMounjaro$395$27,82525 claims
GSKTrelegy Ellipta$166$11,02217 claims
AbbVieSynthroid$565$1,61216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 14,618 family providers in Florida.

Other family in Riverview

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →